FNA stands for fine needle aspiration, a minimally invasive procedure that uses a thin needle to extract cells from a lump or mass in your body. It’s one of the most common ways doctors investigate whether a suspicious growth is benign or cancerous, particularly in the thyroid, breast, and lymph nodes. If your doctor has recommended an FNA, here’s what to expect and what your results will mean.
How Fine Needle Aspiration Works
The concept is straightforward: a very thin needle (typically 23 to 25 gauge, similar to the needles used for blood draws) is inserted into a lump or nodule, and gentle suction pulls out a small sample of cells. The needle makes several quick back-and-forth movements over about 5 to 10 seconds to collect enough material. Those cells are then spread onto slides and examined under a microscope by a pathologist.
For lumps you can feel near the surface, the needle is simply guided by touch. For deeper or harder-to-reach growths, ultrasound imaging is used to guide the needle in real time. Ultrasound guidance has significantly reduced the rate of inconclusive samples and false negatives, because the doctor can see exactly where the needle tip is and target the most suspicious-looking part of a mass while avoiding blood vessels.
Where FNA Is Most Commonly Used
Thyroid nodules are the single most common reason for an FNA. Most thyroid nodules are harmless, but FNA is the standard way to check. It’s also widely used for breast lumps, swollen lymph nodes, and masses in the salivary glands or soft tissues. Essentially, any lump close enough to the surface to reach with a needle is a candidate.
What the Procedure Feels Like
FNA generally does not require local anesthesia. Most people describe it as a brief pinch or pressure, roughly comparable to a standard blood draw. The actual sampling takes only seconds, though the full appointment (including preparation and observation afterward) is longer. After the needle is removed, you’ll press on the site for a few minutes, and your doctor may ask you to stay for a 20- to 30-minute observation period before you leave.
Complications are uncommon. Studies of thyroid FNA find that 0% to 6.4% of patients develop a small bruise or hematoma at the needle site. Serious complications like vocal cord issues or blood vessel injury are rare enough to appear only in isolated case reports. One concern people sometimes hear about is “needle tract seeding,” where cancer cells spread along the path of the needle. Research puts this risk at 0.02% to 0.19%, making it extremely unlikely.
FNA vs. Core Needle Biopsy
You may hear your doctor mention a core needle biopsy as an alternative. The key difference is the size of the sample. FNA collects individual cells, while a core biopsy cuts out a tiny cylinder of intact tissue. That larger sample lets pathologists see the structure of the tissue, not just the cells, which provides more information. In breast lesions, for example, core biopsy sensitivity ranges from 85% to 100%, compared to 35% to 95% for FNA. Core biopsies can also test for specific markers (like hormone receptor status in breast cancer) more reliably.
The tradeoff is that core biopsies require local anesthesia, use a larger needle, and carry a slightly higher risk of bruising and discomfort. FNA’s main advantages are its simplicity, lower cost, and the fact that patients on blood thinners can often have it done without stopping their medication. Most experienced providers continue low-dose aspirin therapy before a thyroid FNA without issue, though practices vary for stronger blood thinners.
Understanding Your FNA Results
For thyroid nodules, results are reported using a six-category system called the Bethesda classification. Each category corresponds to a different estimated risk of cancer:
- Category I (Nondiagnostic): The sample didn’t contain enough cells to evaluate. Cancer risk is 1% to 4%. You’ll likely need a repeat FNA.
- Category II (Benign): No signs of cancer. Risk is 0% to 3%. This is the most common result, and typically no further action is needed beyond routine monitoring.
- Category III (Atypia of Undetermined Significance): Some unusual-looking cells, but not clearly abnormal. Cancer risk is 5% to 15%. Your doctor may recommend a repeat FNA or additional molecular testing.
- Category IV (Follicular Neoplasm): A growth pattern that could be benign or cancerous. Risk is 15% to 30%. Surgery to remove part of the thyroid is often recommended to get a definitive answer.
- Category V (Suspicious for Malignancy): Cells that look very likely cancerous but fall short of a definitive diagnosis. Risk is 60% to 75%.
- Category VI (Malignant): Cancer is confirmed. Risk is 97% to 99%.
For breast and lymph node FNAs, a similar spectrum exists, though without the same standardized numbering. Results typically come back as benign, suspicious, malignant, or insufficient. An insufficient sample doesn’t mean something is wrong; it just means the pathologist needs more cells and you may need a second procedure or a core biopsy.
How Accurate Is FNA?
For thyroid nodules, FNA has a sensitivity of about 90% and a specificity of 79%, with a false-negative rate around 2%. That means if FNA says a nodule is benign, it’s correct the vast majority of the time. Larger nodules (4 cm or bigger) have a slightly higher false-negative rate of about 4.3%, which is why doctors sometimes recommend additional monitoring or a core biopsy for very large masses.
In breast tissue, FNA accuracy is more variable and depends heavily on whether the lump can be felt. For non-palpable breast lesions, the rate of inconclusive results can be as high as 34% to 57%, which is one reason core biopsy has become the preferred first-line approach for breast abnormalities at many centers. FNA remains highly useful for thyroid nodules, lymph nodes, and salivary gland masses, where its accuracy is consistently strong.
Preparing for an FNA
There’s very little preparation required. No fasting is necessary. If you take blood thinners, let your doctor know ahead of time. Low-dose aspirin is generally fine to continue, but stronger anticoagulants may need to be paused depending on your provider’s judgment. Wear comfortable clothing with easy access to the area being biopsied. Results typically come back within a few days to a week, depending on the lab.